No Data
Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
President Joe Biden's shaky debate performance this week is stirring doubts among Democrats about his viability for reelection. As doubts about the president's electability circulate, questions around
Aurora Cannabis Shoots For $512M Market: Marijuana Stock Analyst Initiates Coverage With Neutral
Aurora Cannabis (NASDAQ:ACB), a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo Zuanic, a seasoned marijuana stock analyst from Zuanic & Associates, has init
Shares of Cannabis Stocks Are Trading Lower. The Sector May Be Moving as Investors Assess Thursday's Presidential Debate and 2024 Election Outlook.
Shares of Cannabis Stocks Are Trading Lower. The Sector May Be Moving as Investors Assess Thursday's Presidential Debate and 2024 Election Outlook.
Zuanic & Associates Initiates Coverage On Aurora Cannabis With Neutral Rating
Zuanic & Associates analyst Pablo Zuanic initiates coverage on Aurora Cannabis (NASDAQ:ACB) with a Neutral rating.
Canadian Vs. U.S. Cannabis Companies: Who Is Winning The Market Race To Weed Profits?
The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to rec
Roth MKM Maintains Aurora Cannabis(ACB.US) With Hold Rating, Cuts Target Price to $5.86
Roth MKM analyst William Kirk maintains $Aurora Cannabis(ACB.US)$ with a hold rating, and adjusts the target price from $5.9 to $5.86.According to TipRanks data, the analyst has a success rate of 41.8